Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · abrdn Life Sciences Investors (HQL)

Tekla Life Sciences Investors (HQL) replaces Deloitte with KPMG as auditor

Neutral Impact 3 of 5 other Written later

Deloitte & Touche resigned as the independent auditor of Tekla Life Sciences Investors on September 6, 2023, citing an anticipated independence issue tied to a pending transaction between Tekla Capital Management LLC and abrdn Inc. The fund's board approved KPMG LLP as its auditor on September 7, 2023, for the fiscal year ending September 30, 2023, and the filing reports no disagreements or reportable events with Deloitte.

Key points

  • Deloitte resigned on September 6, 2023, due to an anticipated independence issue linked to a pending Tekla Capital Management LLC and abrdn Inc. transaction.
  • The Audit Committee approved the resignation on September 7, 2023, and the board approved KPMG LLP the same day.
  • Deloitte's reports for the fiscal years ended September 30, 2022 and 2021 contained no adverse or disclaimer opinion and were not qualified or modified.
  • No disagreements or reportable events with Deloitte occurred in the two most recent fiscal years or the interim period through September 6, 2023.

The filing

Companyabrdn Life Sciences Investors (HQL)
Form8-K, current report
Filed with the SECSep 12, 2023, 5:06 PM ET
Accession number0001104659-23-100077

Items reported: 4.01 Auditor Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 12, 2023.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.